INFU icon

InfuSystem Holdings

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 66.7%
Negative

Neutral
Seeking Alpha
7 days ago
InfuSystem Holdings, Inc. (INFU) Q4 2025 Earnings Call Transcript
InfuSystem Holdings, Inc. (INFU) Q4 2025 Earnings Call Transcript
InfuSystem Holdings, Inc. (INFU) Q4 2025 Earnings Call Transcript
Positive
Zacks Investment Research
7 days ago
InfuSystems Holdings, Inc. (INFU) Q4 Earnings Beat Estimates
InfuSystems Holdings, Inc. (INFU) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.04 per share a year ago.
InfuSystems Holdings, Inc. (INFU) Q4 Earnings Beat Estimates
Neutral
Business Wire
7 days ago
InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025.
InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025
Neutral
Business Wire
14 days ago
InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026.
InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Positive
Seeking Alpha
1 month ago
InfuSystem: Regulatory Backed Market Catalyst
InfuSystem: Regulatory Backed Market Catalyst
InfuSystem: Regulatory Backed Market Catalyst
Neutral
Business Wire
2 months ago
Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026.
Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026
Positive
Seeking Alpha
3 months ago
InfuSystem Stock: Margin Expansion And Growth Strategy To Drive Strong Gains
InfuSystem Holdings offers strong growth potential and appears attractively valued after reporting positive Q3 2025 earnings results. INFU's Patient Services segment, especially oncology and wound care, is driving revenue growth, while Device Solutions faced a temporary decline. Margin improvements, new contracts, and the Apollo acquisition are enhancing profitability and expanding INFU's market share and efficiency.
InfuSystem Stock: Margin Expansion And Growth Strategy To Drive Strong Gains
Neutral
Business Wire
3 months ago
InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025.
InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025
Positive
Seeking Alpha
3 months ago
InfuSystem Set To Be A Cash Cow In 2026
InfuSystem (INFU) is prioritizing profitability and margin expansion under new CEO Carrie Lachance, shifting focus from unprofitable revenue streams. INFU's integration of Apollo Medical's billing system and new ERP is expected to drive significant operational efficiencies and margin gains in FY2026. Capital discipline enables INFU to repurchase shares and reduce debt, while growth opportunities in Wound Care and Oncology remain robust.
InfuSystem Set To Be A Cash Cow In 2026
Positive
Zacks Investment Research
3 months ago
Wall Street Analysts Predict a 40% Upside in InfuSystems Holdings (INFU): Here's What You Should Know
The consensus price target hints at a 40% upside potential for InfuSystems Holdings (INFU). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts Predict a 40% Upside in InfuSystems Holdings (INFU): Here's What You Should Know